ICDcodes.org
FY2027

C79.83Secondary malignant neoplasm of oral cavity

BillableCCNew in FY2027

Is C79.83 billable?

Yes — C79.83 is billable for FY2027. C79.83 is a valid, billable ICD-10-CM code at the highest level of specificity in its branch. C79.83 may be submitted for encounters from October 1, 2026 through September 30, 2027. C79.83 is new in FY2027.

C79.83 at a glance

CodeC79.83
DescriptionSecondary malignant neoplasm of oral cavity
BillableYes
Code setICD-10-CM FY2027
Valid for encountersOctober 1, 2026 – September 30, 2027
FY2027 changeNew in FY2027

Which MS-DRGs does C79.83 group to?

C79.83 sits in MDC 17 and helps define the logic of 3 MS-DRGs (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.

  • 826Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures with MCCsurgical
  • 827Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures with CCsurgical
  • 828Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures without CC/MCCsurgical

As a secondary diagnosis, C79.83 is a complication or comorbidity (CC), which can move a stay into a higher-paying DRG.

Excludes1 — never code together — inherited from C79

The conditions below can never be reported together with C79.83 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.

  • secondary carcinoid tumors (C7B.-)
  • secondary neuroendocrine tumors (C7B.-)

What other codes are in the C79.8 family? (3)